{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:35:25Z","timestamp":1776087325124,"version":"3.50.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/ajp.0b013e318158011a","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T04:13:12Z","timestamp":1236226392000},"page":"64-75","source":"Crossref","is-referenced-by-count":61,"title":["Gabapentin Supplemented With Ropivacain Block of Trigger Points Improves Pain Control and Quality of Life in Trigeminal Neuralgia Patients When Compared With Gabapentin Alone"],"prefix":"10.1097","volume":"24","author":[{"given":"Laurinda","family":"Lemos","sequence":"first","affiliation":[]},{"given":"Sara","family":"Flores","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-12-20210204","first-page":"1001","article-title":"Wall and Melzack's Textbook of Pain. 5th ed","author":"Zakrzewska","year":"2006"},{"key":"R2-12-20210204","first-page":"855","article-title":"Bonica's Management of Pain. 3rd ed","author":"Loeser","year":"2001"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.327.7428.1360","article-title":"Treatment options in trigeminal neuralgia","volume":"327","author":"Merrison","year":"2003","journal-title":"BMJ"},{"issue":"5S","key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0885-3924(03)00064-2","article-title":"Diagnosis and treatment of neuropathic pain","volume":"25","author":"Chong","year":"2003","journal-title":"J Pain Sympt Manag"},{"key":"R5-12-20210204","first-page":"CD005451","article-title":"Carbamazepine for acute and chronic pain","volume":"20","author":"Wiffen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain: rationale and clinical evidence","volume":"6","author":"Jensen","year":"2002","journal-title":"Eur J Pain"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/pgmj.57.663.16","article-title":"Long-term treatment of trigeminal neuralgia with carbamazepine","volume":"57","author":"Taylor","year":"1981","journal-title":"Postgrad Med J"},{"key":"R8-12-20210204","first-page":"199","article-title":"Handbook of Pain Management\u2014A Clinical Companion to Wall and Melzack's Textbook of Pain","author":"Zakrzewska","year":"2003"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1212\/WNL.51.2.611","article-title":"Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients","volume":"51","author":"Khan","year":"1998","journal-title":"Neurology"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200060050-00005","article-title":"Anticonvulsivants for neuropathic pain syndromes: mechanisms of action and place in therapy","volume":"60","author":"Tremont-Lukats","year":"2000","journal-title":"Drugs"},{"key":"R11-12-20210204","first-page":"1727","article-title":"Bonica's Management of Pain. 3rd ed","author":"Rowbotham","year":"2001"},{"key":"R12-12-20210204","first-page":"CD005452","article-title":"Gabapentin for acute and chronic pain","volume":"20","author":"Wiffen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1054\/jpai.2002.122944","article-title":"Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study","volume":"3","author":"Cheshire","year":"2002","journal-title":"J Pain"},{"key":"R14-12-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000008192","article-title":"Low-dose gabapentin combined with either iamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis","volume":"44","author":"Solaro","year":"2000","journal-title":"Eur Neurol"},{"key":"R15-12-20210204","first-page":"905","article-title":"Wall and Melzack's Textbook of Pain. 5th ed","author":"Devor","year":"2006"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/00002512-200219120-00004","article-title":"Management strategies for the treatment of neuropathic pain in the elderly","volume":"19","author":"Ahmad","year":"2002","journal-title":"Drugs Aging"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"R20-12-20210204","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcrc.2005.04.005","article-title":"Randomization and allocation concealment: a practical guide for researchers","volume":"20","author":"Doig","year":"2005","journal-title":"J Crit Care"},{"key":"R21-12-20210204","first-page":"903","article-title":"Wall and Melzack's Textbook of Pain. 5th ed","author":"Breivik","year":"2006"},{"key":"R22-12-20210204","first-page":"847","article-title":"Weiner's Pain Management: A Practical Guide for Clinicians. 7th ed","author":"Manchikanti","year":"2006"},{"key":"R23-12-20210204","first-page":"35","article-title":"Pain Clinical Manual","author":"McCoffery","year":"1999"},{"key":"R24-12-20210204","first-page":"310","article-title":"Bonica's Management of Pain. 3rd ed","author":"Chapman","year":"2001"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3959(97)00005-5","article-title":"The visual analogue pain intensity scale: what is moderate pain in millimeters?","volume":"72","author":"Collins","year":"1997","journal-title":"Pain"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","article-title":"Defining the clinically important difference in pain outcome measures","volume":"88","author":"Farrar","year":"2000","journal-title":"Pain"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0304-3959(01)00484-5","article-title":"Lamotrigine in spinal cord injury pain: a randomized controlled trial","volume":"96","author":"Finnerup","year":"2002","journal-title":"Pain"},{"key":"R28-12-20210204","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","article-title":"Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale","volume":"8","author":"Salaffi","year":"2004","journal-title":"Eur J Pain"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"R30-12-20210204","first-page":"415","article-title":"Wall and Melzack's Textbook of Pain. 5th ed","author":"McQuay","year":"2006"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00005650-198108000-00001","article-title":"The Sickness Impact Profile: development and final revision of a health status measure","volume":"19","author":"Bergner","year":"1981","journal-title":"Med Care"},{"key":"R33-12-20210204","first-page":"329","article-title":"Bonica's Management of Pain. 3rd ed","author":"Turner","year":"2001"},{"key":"R34-12-20210204","first-page":"117","article-title":"Psychological Aspects of Pain: A Handbook for Health Care Providers. Progress in Pain Research and Management","volume":"27","author":"Jamison","year":"2004"},{"key":"R35-12-20210204","article-title":"Design and Analysis of Experiments. 3rd ed","author":"Montgomery","year":"1991"},{"key":"R36-12-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0304-3959(90)90026-A","article-title":"Prolongad relief of neuralgia alter regional anesthetic blocas. A call for further experimental and systematic clinical studies","volume":"43","author":"Arn\u00e9r","year":"1990","journal-title":"Pain"},{"key":"R37-12-20210204","first-page":"574","article-title":"Handbook of Clinical Neurology\u2014Pain, Vol 81 (3rd series)","author":"Nurmikko","year":"2006"},{"key":"R38-12-20210204","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"R39-12-20210204","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1528-1157.1997.tb01251.x","article-title":"The new antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"38","author":"Marson","year":"1997","journal-title":"Epilepsia"},{"key":"R40-12-20210204","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Eng J Med"},{"key":"R41-12-20210204","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"R42-12-20210204","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"R43-12-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-4886(88)90101-X","article-title":"Carbamazepine inhibits spontaneous activity in experimental neuromas","volume":"102","author":"Burchiel","year":"1988","journal-title":"Exper Neurol"},{"key":"R44-12-20210204","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0304-3959(92)90067-L","article-title":"Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction","volume":"48","author":"Devor","year":"1992","journal-title":"Pain"},{"key":"R45-12-20210204","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1523\/JNEUROSCI.19-19-08589.1999","article-title":"Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain","volume":"19","author":"Amir","year":"1999","journal-title":"J Neurosci"},{"key":"R46-12-20210204","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0022-3565(24)38054-1","article-title":"Gabapentin suppresses ectopic discharge and reverses allodynia in neuropathic rats","volume":"288","author":"Pan","year":"1999","journal-title":"J Pharmacol Expl Ther"},{"key":"R47-12-20210204","first-page":"499","article-title":"Wall and Melzack's Textbook of Pain. 5th ed","author":"Sang","year":"2006"},{"key":"R48-12-20210204","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1113\/jphysiol.2003.046110","article-title":"The tetrodoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice","volume":"550","author":"Roza","year":"2003","journal-title":"J Physiol"},{"key":"R49-12-20210204","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanism of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"R50-12-20210204","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug gabapentin (Neurontin) binds to the alpha-2 delta subunit of calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J Bio Chem"},{"key":"R51-12-20210204","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.semcdb.2006.09.002","article-title":"The role of voltage-gated calcium channels in pain and nociception","volume":"17","author":"Gribkoff","year":"2006","journal-title":"Sem Cell Devel Biol"},{"key":"R52-12-20210204","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion \u03b12\u03b4 calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats","volume":"21","author":"Luo","year":"2001","journal-title":"J Neurosci"},{"key":"R53-12-20210204","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2006.09.019","article-title":"Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice","volume":"553","author":"Joshi","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R54-12-20210204","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"R55-12-20210204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","article-title":"Pathophysiology of trigeminal neuralgia: the ignition hypothesis","volume":"18","author":"Devor","year":"2002","journal-title":"Clin J Pain"},{"issue":"2","key":"R56-12-20210204","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/00002508-200006001-00012","article-title":"Anticonvulsivants (antineuropathics) for neuropathic pain syndromes","volume":"16","author":"Backonja","year":"2000","journal-title":"Clin J Pain"},{"issue":"1","key":"R57-12-20210204","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1046\/j.1526-4610.2001.01154-5.x","article-title":"Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia","volume":"41","author":"Rosen","year":"2001","journal-title":"Headache"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002508-200801000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:08:21Z","timestamp":1738976901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-200801000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e318158011a","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}